newsfilter
← Latest News
GlobeNewswire·

New Anti-Cancer Opportunities Revealed for Hepion Pharmaceuticals' Rencofilstat in Cancer Screening Program

- 850 cancer cell lines screened in Broad Institute's PRISM lab - - Rencofilstat active on 220 cancer cell lines spanning 86% of cancer types – EDISON, N.J., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals,